fundvisualizer.com

Lord Abbett Micro Cap Growth CLCMGX

Performance (before sales charge)

As of 02/28/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 01/31/2023
Stock
95.40%
Non-U.S. Stock
4.60%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.00%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 01/31/2023

Basic materials

0.00%

Consumer cyclical

5.73%

Financial services

3.43%

Real estate

0.00%

Consumer defensive

5.09%

Health care

39.46%

Utilities

0.00%

Communication services

4.53%

Energy

1.03%

Industrials

13.99%

Technology

25.34%

Top 10 holdings

As of 01/31/2023

Ventyx Biosciences Inc
3.52%
Agilysys Inc
3.26%
Impinj Inc
3.13%
Rambus Inc
2.94%
Krystal Biotech Inc
2.59%
TransMedics Group Inc
2.59%
Arcellx Inc
2.50%
Pliant Therapeutics Inc Ordinary Shares
2.37%
Heritage-Crystal Clean Inc
2.10%
Calix Inc
2.06%
Fund assets

$228.45 Million

Share class

C

Morningstar category

Small Growth

Expense ratio

2.16%

Investment objective

Growth

Documents